
Opinion|Videos|January 31, 2025
Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education
This video segment explores the challenges of managing neurologic toxicities, including ICANS, in CAR-T therapy, highlighting monitoring strategies, tools for early detection, and approaches to communicating risks with patients and caregivers.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Neurologic toxicities, including ICANS, present unique challenges: How do you monitor for and manage these events in your practice?
- What tools or assessments do you use to detect early signs of neurotoxicity?
- How do you explain these risks to patients and their caregivers?
Advertisement
Related to this article

At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.

At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.

At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.

ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.

At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.

APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.

At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Pirtobrutinib for Untreated CLL/SLL
2
Prior Authorization, Costs Limit Access to Oral Blood Cancer Drugs
3
Outlining Tiered Self-Care Plans for Oncology Nurses
4
Tailoring Toxicity Monitoring for ADCs in Metastatic Triple-Negative Breast Cancer
5

